Skip to main navigation Skip to search Skip to main content

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

  • the TRILOGY ACS Investigators
  • Duke University
  • University of Alberta
  • University of Edinburgh
  • Auckland District Health Board
  • University of Toronto
  • North West Hospital Group
  • Harvard University
  • University of Copenhagen
  • Universidad Nacional de Córdoba
  • University of Parma
  • Universidade de São Paulo
  • Albany Medical College
  • Sinai Hospital of Baltimore
  • Cardinal Stefan Wyszynski Institute of Cardiology
  • Milpark Hospital
  • University of Texas at Dallas
  • Hospital Central Ignacio Morones Prieto
  • M.D. Strazhesko Institute of Cardiology AMS Ukraine
  • Bikur Cholim Hospital
  • Medical Center Manila
  • Kerckhoff Heart Center
  • Onassis Cardiac Surgery Center
  • Medical University Sofia
  • Hacettepe University
  • National Taiwan University
  • Semmelweis University
  • University of Zagreb
  • Pontificia Universidad Católica de Chile
  • Carol Davila University of Medicine and Pharmacy
  • Eli Lilly
  • Flinders University
  • Klinik Ottakring
  • New York University
  • KU Leuven
  • Grochowski Hospital
  • Mayo Clinic Rochester, MN
  • Sorbonne Université
  • London School of Hygiene and Tropical Medicine
  • Nottingham University Hospitals NHS Trust
  • Rhode Island Hospital

Research output: Contribution to journal › Journal article › peer-review

Fingerprint

Dive into the research topics of 'Prasugrel versus clopidogrel for acute coronary syndromes without revascularization'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science